medigraphic.com
ISSN 0016-3813 (Print)

2015, Number 5

<< Back Next >>

Gac Med Mex 2015; 151 (5)

Dementia in Mexico: The need for a National Alzheimer´s Plan

Gutiérrez-Robledo LM, Arrieta-Cruz I

Language: Spanish
References: 17
Page: 667-673
PDF size: 82.82 Kb.


ABSTRACT

Dementia is one of the facts than most contributes to the disability and dependence in elderly people. Alzheimer´s disease is the cause more common of dementia in the world. In Mexico, the prevalence of Alzheimer´s disease is 7.3% and incidence of 27.3 per 1,000 people/year. Mexican population studies have determined that Alzheimer´s disease is highly associated to women and their risk to develop it is increased with metabolic syndrome, cardiovascular disease, or depression. The projections are that there will be 3.5 million elderly people affected by Alzheimer´s disease by 2050 in Mexico; this will have a major impact on the healthcare system. The National Institute of Geriatrics from Mexico’s Ministry of Health has released a first proposal for a National Alzheimer and Other Dementias’ Plan. The central aim of this plan is to promote the well being of people affected by Alzheimer´s disease and their families through of the strengthening of the Mexican healthcare system and the support of other responsible institutions.


REFERENCES

  1. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008. http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf.

  2. Alzheimer’s disease international (ADI) Policy Brief for Heads of Government: The Global Impact of Dementia. Alzheimer’s disease International. London, UK; 2013. http://www.alz.co.uk/research/GlobalImpactDementia2013. pdf.

  3. Prince M, Prina M, Guerchet M. World Alzheimer Report 2013: Journey of Caring. An analysis of long-term care for dementia. Alzheimer’s Disease International. London, UK; 2013.

  4. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112-7.

  5. World Health Organization: Dementia: A Public Health Priority. Washington, DC.; 2012. http://apps.who.int/iris/bitstream/10665/98377/1/9789275318256_ spa.pdf.

  6. Global Action against Dementia. G8 Dementia Summit, UK; 2013 https:// www.gov.uk/government/uploads/system/uploads/attachment_data/ file/265869/2901668_G8_DementiaSummitDeclaration_acc.pdf.

  7. Mejía-Arango S, Miguel-Jaimes A, Villa A, et al. Cognitive impairment and associated factors in older adults in Mexico. Salud Publica Mex. 2007;49:S475-81.

  8. Llibre JJ, Ferri CP, Acosta D, et al. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008;372:464-74.

  9. Prince M, Acosta D, Ferri CP, et al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study. Lancet. 2012;380:50-8.

  10. Mejia-Arango S, Gutierrez LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health. 2011;23:1050-74.

  11. Manrique-Espinoza B, Salinas-Rodríguez A, Moreno-Tamayo KM, et al. Condiciones de salud y estado funcional de los adultos mayores en México. Salud Publica Mex. 2013;55 Supl2:S323-31.

  12. García-Lara JM, Aguilar-Navarro S, Gutiérrez-Robledo LM, et al. The metabolic syndrome, diabetes, and Alzheimer’s disease. Rev Invest Clin. 2010;62:343-9.

  13. Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, et al. Apolipoprotein E epsilon4, Alzheimer’s disease, and cognitive performance in elderly Mexican Mestizos. J Am Geriatr Soc. 2008;56:677-82.

  14. Campos M, Edland SD, Peavy GM. Exploratory study of apolipoprotein E 􀂡4 genotype and risk of Alzheimer’s disease in Mexican Hispanics. J Am Geriatr Soc. 2013;61:1038-4.

  15. ADI/Bupa report, Dementia in the Americas: Current and future cost and prevalence of Alzheimer’s disease and other dementias, London, UK; 2013. https://www.alz.co.uk/sites/default/files/pdfs/dementia-in-the-americas- SPANISH.pdf.

  16. Gutiérrez Robledo LM, Arrieta Cruz I. Plan de acción Alzheimer y otras demencias, México. Instituto Nacional de Geriatría/Secretaría de Salud. http://inger.gob.mx/bibliotecageriatria/acervo/pdf/plan_alzheimer_WEB. pdf México. 2014.

  17. Diplomado Alzheimer y otras demencias (en línea). http://www.geriatria. salud.gob.mx/contenidos/noticias/diplomado_alzheimer_linea.html.




2020     |     www.medigraphic.com